Kura Oncology vergibt Aktienoptionen an neue Mitarbeiter

Kura Oncology, Inc. +4.82% Post

Kura Oncology, Inc.

KURA

9.14

9.28

+4.82%

+1.53% Post

Kura Oncology Inc. hat am 2. Februar 2026 Aktienoptionen zum Erwerb von insgesamt 69.750 Stammaktien an vier neue Mitarbeiter vergeben. Der Ausübungspreis beträgt 8,27 US-Dollar pro Aktie. Die Optionen werden über vier Jahre gestaffelt, wobei 25 % nach einem Jahr und der Rest monatlich über die folgenden 36 Monate vergeben werden, vorbehaltlich der fortgesetzten Unternehmenszugehörigkeit. Die Vergabe erfolgte gemäß dem 2023 Inducement Option Plan und der Nasdaq Listing Rule 5635(c)(4).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9649783) on February 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.